Vaccine Report Card From CDC/FDA is Long Overdue!

Pfizer–BioNTech COVID-19 vaccine at 39% and 42% protection against Delta in Israel and the US, respectively, and lasting less than a year, makes this vaccine worst-in-class and non-viable as a commercial product. Moderna which has more than three times the mRNA than Pfizer–BioNTech per shot is holding up better at 72% protection in a study from Mayo Clinic.

The CDC/FDA holds all the data on differential efficacy of the vaccines and at 8 months into the public program, the agency's vaccine report card to America is long overdue.

Listen to 'The McCullough Report' heard on the America Out Loud Talk Radio Network. There is always much more to learn back at America Out Loud: https://americaoutloud.com.